-
PROVIDERS
REGISTER NOW
Scientific breakthroughs across the cancer continuum: Research from the 2024 ASCO® Annual Meeting
Join us as we engage in a multi-disciplinary discussion around practice changing approaches in patient management across the cancer care journey. -
LIFE SCIENCES
REGISTER NOW
Integrating omics in R&D: A new era of biomedical research
Join us as industry experts discuss the integration of diverse omics data, from next-generation sequencing (NGS) to proteomics, and explore its transformative impact on the research landscape. -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Original Webinar Date:
07/09/2024
Harnessing the power of AI: Optimizing workflows & enhancing testing across the cancer care continuum
Discover how AI is enabling more accurate, personalized, and effective cancer care. We highlight the latest advancements in our technologies, such as One, Lens, Next and Link, that are helping to streamline efficiencies in clinical practices and research processes. With our most recent expansion into the MRD and monitoring space, we are leveraging these technologies to improve patient outcomes and surveillance strategies for both provider and biopharma partners.
Speakers
Ezra Cohen, MD, FASCO
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
Special Guest
Jonathan Ozeran
VP of Generative AI & Head of Tempus One, Tempus
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
Special Guest
Jonathan Ozeran
VP of Generative AI & Head of Tempus One, Tempus
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more